The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
about
PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsThe Sch9 kinase is a chromatin-associated transcriptional activator of osmostress-responsive genes.Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesuPAR and cathepsin B-mediated compartmentalization of JNK regulates the migration of glioma-initiating cellsA new microsphere-based immunoassay for measuring the activity of transcription factorsDifferential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cellsAccelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2.Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells.Identification and expression analysis of ras gene in silkworm, Bombyx moriMultiple signals converge on a differentiation MAPK pathway.MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasionCrosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesBiochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells.Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective.Enhanced estrogen-induced proliferation in obese rat endometrium.CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer CellsAn emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancerOncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogeneMild hypothermia in combination with minimally invasive evacuation of hematoma reduces inflammatory damage in patients via the nuclear factor-κB pathway.Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.The regulation of Th1 responses by the p38 MAPKERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioningMAPK signaling triggers transcriptional induction of cFOS during amino acid limitation of HepG2 cells.Imbalanced expression of mitogen-activated protein kinase phosphatase-1 and phosphorylated extracellular signal-regulated kinases in lung squamous cell carcinoma.MK3 modulation affects BMI1-dependent and independent cell cycle check-points.Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.Altered glucose metabolism in Harvey-ras transformed MCF10A cellsPEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase DCocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTRHypoxia-induced and stress-specific changes in chromatin structure and function.Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes.Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformationAnalyses of linker histone--chromatin interactions in situ.Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation.Epigenetic events in malignant melanoma.Polarity proteins as regulators of cell junction complexes: implications for breast cancer.
P2860
Q26862544-14E69CBA-F21E-4879-9171-683AEF945781Q27934019-FD82F4B6-96B6-45F0-B1FF-CEAE04216320Q28085631-F1F4F6BA-53D5-40DD-A71F-D5181249CDF2Q28237374-9514CEA3-ECBF-434F-8E09-091D96A633ECQ28386784-C76C6AC5-0109-406F-A9ED-F0F1E4B62EB8Q28481683-DEC1987A-5DEF-4AC9-9ADA-07DBCC1B13DCQ30315937-4EE96C37-8385-47F8-B2C1-9E7E1F84E0F5Q30594829-34128395-F0CA-477D-8DAD-BF3358603D0AQ33299761-185A9BF1-1002-496D-A2BB-1A25CF7F218AQ33516862-6C4C443F-C97B-42D4-935A-4700223683E0Q33545219-22143B62-C513-4718-A272-8A82EED3FF43Q33599411-B8481089-94A4-47B5-AB26-1CBB4A5CC102Q33636430-2DB6A353-8069-4DEA-8EDD-9F2AA46E6A14Q33652374-CFE9B4C7-9B29-49A9-9A17-D3D939F46751Q33817720-83302101-985A-4360-A4BC-9FC5DCC23871Q33894510-1F1AD1F1-304A-4B03-A4CD-D6AF3B7DFFEFQ34003423-61D5DAD8-2E20-4FD1-83C8-EF5215DFA140Q34037337-C00D953A-EC7C-48B3-BD7E-F6781574A549Q34268347-67C0B8E2-3E83-4D3A-87A4-75FD7BDA141DQ34287626-E3627FE8-791A-46CF-9298-A3102706D219Q34305782-D5A9D998-F5E5-41D3-B8DE-0F44CE73CAA7Q34444023-97EE1802-F3F9-41C4-872F-CD385F185D47Q34621624-5B1103F2-2F28-47A3-A838-835D36F6B9A2Q34630433-B31D04A3-EBBB-4D75-AAF1-57CE3D3BEDCCQ34667105-0225CBF6-EAA2-401A-8EB5-EF45431F9154Q35044566-E072B80F-93C3-4DAD-B649-0B8577C320E9Q35301861-2011D5F3-447E-4DD9-B643-EC6E10919E88Q35597530-B7BB3EE3-CC46-41D6-96CC-A0D0370869D6Q35616841-2BEC7738-5063-48F1-96B9-0B475F9574D2Q35742791-E354C437-CD63-4E28-B0D4-739FDB10163CQ35809595-CE060DC3-2FA4-4400-A871-B3208D200443Q35894061-838FD8BD-D7D1-4D8E-A832-02BBE1B9AEC6Q35901931-5AD32ABD-B575-4263-BF22-7EBBE12775EEQ35906375-82376F74-7138-41D0-BA3D-B05482223388Q36395100-6BFA654A-53DF-400F-8EEA-6FF550F747ADQ36528556-93EAF931-D20F-4DEE-AB45-72C27CFAB0E2Q36579334-C01A1D12-058B-4E6E-BFFE-A8BED916E887Q36735842-0168E778-E1CE-4ACB-90E4-AE4DC55F24FEQ36764224-93035E9F-AAC4-4D96-B894-943D1C685819Q36828937-A95EB31B-AD84-4DC6-8CDC-53615ECA1FC1
P2860
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@ast
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@en
type
label
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@ast
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@en
prefLabel
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@ast
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@en
P2093
P2860
P356
P1476
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
@en
P2093
Bojan Drobic
James R Davie
Katherine L Dunn
Paula S Espino
P2860
P356
10.1139/O04-121
P577
2005-02-01T00:00:00Z